A study has been conducted on the use of a chatbot to facilitate transitions from primary to specialist care. The study is described as a randomized controlled trial, although some reports also mention a pragmatic, cluster-randomized trial. The focus of the study appears to be unclear, with some outlets mentioning its application in primary care, while others discuss unrelated medical topics such as PCOS, arrhythmia, and gout.